• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Home
  • LinkedIn
  • Twitter

  • About Us
    • Overview
    • Executive Committee
    • Board Of Directors
    • Partners
  • Science
    • Overview
    • Approach
    • Technology
      • shRNA
      • shARC Platform
    • Scientific Publications
  • Pipeline
  • Newsroom
    • Press Releases
    • Events
    • Media Center
  • Investors
    • Overview
    • Analyst Coverage
    • Corporate Governance
    • Regulated Information
    • Shareholders Information
    • Shareholders Meeting
  • Careers
  • Contact Us

Full Year 2022 Financial Results and Business Update Conference Call

March 17, 2023 By clonez@celyad.com

Conference call at 8 a.m. ET / 1 p.m. CET

Dial # +1-877-407-9716 or +1-201-493-6779 (US, International), +32 (0) 800-73-904 or +32 (0) 800-73-566 (BE)

Third Quarter 2022 Financial Results

August 8, 2022 By Celyad Oncology

First Half 2022 Financial Results

May 25, 2022 By Celyad Oncology

Call at 8 a.m. ET / 2  p.m. CET

H.C. Wainwright Global Investment Conference

May 17, 2022 By Celyad Oncology

On-demand starting May 24, 7 a.m ET / 1 p.m. CET

Full Year 2021 Financial Results and Recent Business Highlights

March 17, 2022 By Celyad Oncology

Call at 8 a.m. ET / 1 p.m. CET

11th Annual SVB Leerink Global Healthcare Conference

January 31, 2022 By Celyad Oncology

Presentation Time: 8:00 a.m. ET / 2 p.m. CET

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

Footer

Celyad Oncology

Celyad Oncology Logo
  • About
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Contact Us
  • LinkedIn
  • Twitter

Copyright © 2020 All Rights Reserved.

  • Cookie Policy |
  • Privacy Policy |
  • Terms of Use